Marco Borgi

Dr. Marco Borgi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in European Journal of Internal Medicine
Verified
Journal Article
Open access
MPMarco Proietti
Marco Proietti
Giulio Francesco RomitiGiulio Francesco Romiti
Giulio Francesco Romiti
MVMarco Vitolo
Marco Vitolo
MBMarco Borgi
Marco Borgi
ARArianna Di Rocco
Arianna Di Rocco
Gregory LipGregory Lip
Gregory Lip
In recent years, attention to subclinical atrial fibrillation (SCAF), defined as the presence of atrial high-rate episodes (AHREs), in patients with cardiac implantable electronic devices (CIEDs), has gained much interest as a determinant of clinical AF and stroke risk. We aim to perform a systematic review and meta-regression of the available scientific evidence regarding the epidemiology of SCAF in patients receiving CIEDs. PubMed and EMBASE were searched for all studies documenting the prevalence of AHREs in patients (n=100 or more, <50% with history of AF) with CIEDs from inception to 20th August 2021, screened by two independent blind reviewers. This study was registered in PROSPERO: CRD42019106994. Among the 2614 results initially retrieved, 54 studies were included, with a total of 72,784 patients. Meta-analysis of included studies showed a pooled prevalence of SCAF of 28.1% (95%CI: 24.3-32.1%), with high heterogeneity between studies (I2=98%). A multivariable meta-regression was able to explain significant proportion of heterogeneity (R2=61.9%, p<0.001), with age and follow-up time non-linearly, directly and independently associated with occurrence of SCAF. Older age, higher CHA2DS2-VASc score, history of AF, hypertension, CHF, and stroke/TIA were all associated with SCAF occurrence. In this systematic review and meta-regression analysis, SCAF was frequent among CIED recipients and was non-linearly associated with age and follow-up time. Older age, higher thromboembolic risk, and several cardiovascular comorbidities were associated with presence of SCAF.

13 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Valeria RaparelliValeria Raparelli
Valeria Raparelli
Giulio Francesco RomitiGiulio Francesco Romiti
Giulio Francesco Romiti
VSValeria Spugnardi
Valeria Spugnardi
MBMarco Borgi
Marco Borgi
Roberto CangemiRoberto Cangemi
Roberto Cangemi
GVGiacomo Visioli
Giacomo Visioli
Background: The reasons behind low adherence to the Mediterranean diet (Med-diet) are still not entirely known. We aimed to evaluate the effect of biological (i.e., sex-related) and psycho-socio-cultural (i.e., gender-related) factors on Med-diet adherence. Methods: Baseline Med-diet adherence was measured using a self-administered questionnaire among adults with ischemic heart disease (IHD) from the EVA (Endocrine Vascular Disease Approach) study. A multivariable analysis was performed to estimate the effect of sex- and gender-related factors (i.e., identity, roles, relations, and institutionalized gender) on low adherence. Results: Among 366 participants (66 ± 11 years, 31% women), 81 (22%) adults with low adherence demonstrated higher rates of diabetes, no smoking habit, lower male BSRI (Bem Sex Role Inventory) (median (IQR) 4.8 (4.1 to 5.5) vs. 5.1 (4.5 to 5.6) and p = 0.048), and higher Perceived Stress Scale 10 items (PSS-10) (median (IQR) 19 (11 to 23) vs. 15 (11 to 20) and p = 0.07) scores than those with medium-high adherence. In the multivariable analysis, only active smoking (odds ratio, OR = 2.10, 95% confidence interval, CI 1.14 to 3.85 and p = 0.017), PPS-10 (OR = 1.04, 95% CI 1.00 to 1.08, and p = 0.038) and male BSRI scores (OR = 0.70, 95% CI 0.52 to 0.95, and p = 0.021) were independently associated with low adherence. Conclusions: Male personality traits and perceived stress (i.e., gender identity) were associated with low Med-diet adherence regardless of the sex, age, and comorbidities. Therefore, gender-sensitive interventions should be explored to improve adherence in IHD.

Verified
Journal Article
Open access
PDF file
GLGiulia Laterra
Giulia Laterra
GDGiuseppe Dattilo
Giuseppe Dattilo
MCMichele Correale
Michele Correale
NBNatale Daniele Brunetti
Natale Daniele Brunetti
CAClaudia Artale
Claudia Artale
MCMarco Contarini
Marco Contarini
Atrial fibrillation (AF) is the most common cardiac arrhythmia in adults. The left atrial appendage (LAA) is the most likely source of thrombus formation in patients with non-valvular atrial fibrillation (NVAF). Left atrial appendage closure (LAAC) represents an effective alternative to NOAC in patients with NVAF. Expert consensus documents recommend intraprocedural imaging by means of either transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) in addition to standard fluoroscopy to guide LAAC. TEE-guided LAAC usually requires general anesthesia. The ICE technique is a “minimalist approach”, without general anesthesia, but ICE imaging techniques are not yet simplified and standardize, and the ICE may result in inferior image quality compared with that of TEE. Another “minimalist approach” can be the use of ICE via the esophageal route (ICE-TEE), that jet is validated to identify the presence of LAA thrombi in patients and to perform other procedures. In our cath laboratory ICE-TEE to guide LAAC is used in some complex patients. Indeed, our single center experience suggests that ICE-TEE could be a good alternative imaging technique to guide LAAC procedure without general anesthesia.

6 January 2024 in Heart, Vessels and Transplantation
Verified
Journal Article
Open access
PDF file
MBMarco Borgi
Marco Borgi
GZGiuseppe Biondi Zoccai
Giuseppe Biondi Zoccai
FVFrancesco Versaci
Francesco Versaci
In the recently published clinical practice guidelines by the American Heart Association/American College of Cardiology, a central part has been dedicated to the revascularization, as new evidence came up increasing our knowledge on this relevant topic. Providing symptom relief, preventing major adverse cardiovascular events and improving long-term survival is ultimately the aim of coronary revascularization. Such ambitious goals should be actively pursued, as suggested thoroughly in the text, sharing the clinical decision making with the patient. Aim of this commentary is to highlight critical messages from the recent guideline, especially in complex clinical scenarios such as angiographically intermediate coronary artery stenoses, significant left main disease and multivessel disease with severe left ventricular dysfunction.

1 May 2025 in Minerva Cardiology and Angiology
Verified
Journal Article
Closed access
MBMarco Borgi
Marco Borgi
FMFrancesco Mannaioli
Francesco Mannaioli
FVFrancesco Versaci
Francesco Versaci
Article: Decoding immune involvement in acute coronary syndromes: insights from novel biomarker discovery - Minerva Cardiology and Angiology 2025 May 05 - Minerva Medica - Journals

1 May 2026 in Minerva Cardiology and Angiology
Verified
Journal Article
Closed access
MBMarco Borgi
Marco Borgi
ALAttilio Lauretti
Attilio Lauretti
FVFrancesco Versaci
Francesco Versaci